semaglutide ruling Novo Nordisk protects US patients

Semaglutide has been linked to medullary thyroid carcinoma (MTC) in humans and is contraindicated in patients with a personal or family history of MTC or in patients with multiple endocrine neoplasia syndrome type 2 (MEN 2)

Without randomized, long-term studies on the use of GLP-1 RAs in a large sample size of HS patients with a wide range of ages, comorbidities, risk factors, and sexes and without any confounding factors, it is difficult to conclusively determine whether GLP-1 RAs are a definitive treatment for HS

Come and learn to love your body and live your life (and quiet that critical voice!) with The Body Positive's co-founder Connie Sobczak

Pollard, M

C., Menaldo, D